II-VI Incorporated to Present a Broad Portfolio of Products at SPIE Photonics West 2016
Feb 08, 2016 21:05 pm UTC| Business
PITTSBURGH, Feb. 08, 2016 -- II-VI Incorporated (NASDAQ:IIVI), a global leader in engineered materials and opto-electronic components, today announced that it will present a broad portfolio of products at SPIE Photonics...
Tyson Foods to Webcast CAGNY Presentation
Feb 08, 2016 21:05 pm UTC| Business
SPRINGDALE, Ark., Feb. 08, 2016 -- Tyson Foods, Inc. (NYSE:TSN) will webcast its presentation at the Consumer Analyst Group of New York (CAGNY) conference on Tuesday, February 16, at 1:45 p.m. EST. Representing Tyson...
CTG to Announce Fourth Quarter and Fiscal Year 2015 Financial Results on February 23, 2016
Feb 08, 2016 21:05 pm UTC| Business
BUFFALO, N.Y., Feb. 08, 2016 -- CTG (NASDAQ:CTG), an information technology (IT) services and solutions company, today announced it will release fourth quarter and fiscal year 2015 financial results on Tuesday, February...
Corium Reports First Quarter Fiscal 2016 Financial Results
Feb 08, 2016 21:03 pm UTC| Business
MENLO PARK, Calif., Feb. 08, 2016 -- Corium International,Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products,...
Cutera Reports Fourth Quarter 2015 Results
Feb 08, 2016 21:03 pm UTC| Business
Sixth Consecutive Quarter of Double-Digit Revenue GrowthRevenue Increased 18% to $30.0 million EPS: $0.15 and Non-GAAP EPS: $0.25Generated $3.9 Million of Cash from OperationsBoard Approved $10 million of Stock Repurchase...
Feb 08, 2016 21:01 pm UTC| Business
THE WOODLANDS, Texas, Feb. 08, 2016 -- Repros Therapeutics Inc.® (Nasdaq:RPRX) today announced that on February 4, 2016, the Company attended a productive meeting with FDA reviewers and senior leaders to discuss...
AGTC Announces Financial Results for the Quarter Ended December 31, 2015
Feb 08, 2016 21:01 pm UTC| Business
GAINESVILLE, Fla., and CAMBRIDGE, Mass., Feb. 08, 2016 -- Applied Genetic Technologies Corporation (NASDAQ:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene...